AstraZeneca breaks ground at $4.5 billion Virginia plant as drugmakers court Trump
PositiveFinancial Markets

AstraZeneca has officially begun construction on a $4.5 billion manufacturing plant in Virginia, a significant investment that highlights the company's commitment to expanding its production capabilities in the U.S. This move comes as pharmaceutical companies seek to strengthen their ties with the current administration, particularly with Trump, who has been vocal about supporting domestic manufacturing. The new facility is expected to create thousands of jobs and boost the local economy, making it a crucial development for both the company and the region.
— Curated by the World Pulse Now AI Editorial System